You are here

  • Home
  • Archive
  • Volume 71, Issue Suppl 3
  • SAT0144 Can rheumatoid arthritis (RA) incomplete secondary responders to TNF-alpha attain an efficacious and safe response by switching to certolizumab pegol?

Article metrics

Article menu
Download PDFPDF
Scientific Abstracts
Poster Presentations
Posters
Rheumatoid arthritis – anti-TNF therapy
SAT0144 Can rheumatoid arthritis (RA) incomplete secondary responders to TNF-alpha attain an efficacious and safe response by switching to certolizumab pegol?

 

Online download statistics by month:

Online download statistics by month: February 2014 to March 2024

AbstractFullPdf
Feb 2014400
Mar 20141202
Apr 2014300
May 2014500
Jun 2014402
Jul 2014801
Aug 2014900
Sep 2014801
Oct 2014401
Nov 2014400
Dec 2014300
Feb 2015201
Mar 2015200
Apr 2015900
May 2015301
Jun 2015300
Jul 2015701
Aug 2015500
Sep 2015500
Oct 2015200
Nov 2015802
Dec 2015601
Jan 2016300
Feb 2016201
Mar 2016501
Apr 2016400
May 2016400
Jun 2016600
Jul 2016400
Aug 2016200
Sep 2016300
Oct 20161100
Nov 20161000
Dec 2016600
Jan 20171101
Feb 2017501
Mar 2017901
Apr 2017801
May 2017200
Jun 20171701
Jul 20171200
Aug 20171600
Sep 2017800
Oct 2017600
Nov 2017600
Dec 20171802
Jan 20181400
Feb 20181400
Mar 2018600
Apr 2018800
May 20181400
Jun 2018200
Jul 2018800
Aug 20182400
Sep 20181402
Oct 2018400
Nov 20181202
Dec 2018400
Jan 2019400
Feb 2019400
Mar 2019400
Apr 2019200
May 2019400
Jun 2019200
Jul 2019600
Aug 20191600
Sep 2019400
Dec 2019800
Feb 2020400
Jun 2020601
Jul 2020600
Aug 2020100
Sep 20201101
Nov 2020300
Dec 2020400
Jan 2021200
Mar 2021401
Apr 2021400
Aug 2021100
Oct 20211200
Nov 2021801
Dec 2021600
Feb 2022400
Mar 2022600
Apr 2022200
May 2022800
Jun 2022200
Jul 20221800
Aug 2022800
Sep 2022400
Oct 2022200
Nov 20222201
Dec 20221401
Jan 2023400
Feb 2023600
Mar 20231201
Apr 2023200
May 2023200
Jun 20231202
Jul 2023200
Sep 2023800
Nov 2023200
Dec 2023600
Jan 2024200
Feb 2024200
Mar 2024200
Total696035